Innate Pharma Stock Price History
| IPHA Stock | USD 1.95 0.07 3.47% |
Below is the normalized historical share price chart for Innate Pharma extending back to October 17, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Innate Pharma stands at 1.95, as last reported on the 19th of March, with the highest price reaching 2.04 and the lowest price hitting 1.95 during the day.
If you're considering investing in Innate Stock, it is important to understand the factors that can impact its price. Innate Pharma holds Efficiency (Sharpe) Ratio of -0.0104, which attests that the entity had a -0.0104 % return per unit of risk over the last 3 months. Innate Pharma exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Innate Pharma's Market Risk Adjusted Performance of 0.5584, downside deviation of 6.39, and Risk Adjusted Performance of 0.0553 to validate the risk estimate we provide.
At present, Innate Pharma's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 464 M, whereas Common Stock Total Equity is forecasted to decline to about 2.5 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.38, whereas Price To Sales Ratio is forecasted to decline to 3.47. Innate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of October 2019 | 200 Day MA 2.0594 | 50 Day MA 1.9516 | Beta 0.859 |
Innate |
Sharpe Ratio = -0.0104
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IPHA |
Estimated Market Risk
| 5.05 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Innate Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innate Pharma by adding Innate Pharma to a well-diversified portfolio.
Price Book 5.3864 | Enterprise Value Ebitda (6.94) | Price Sales 5.1214 | Shares Float 33.2 M | Wall Street Target Price 8.015 |
Innate Pharma Stock Price History Chart
There are several ways to analyze Innate Stock price data. The simplest method is using a basic Innate candlestick price chart, which shows Innate Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 24, 2025 | 2.53 |
| Lowest Price | January 16, 2025 | 1.67 |
Innate Pharma March 19, 2025 Stock Price Synopsis
Various analyses of Innate Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Innate Stock. It can be used to describe the percentage change in the price of Innate Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Innate Stock.| Innate Pharma Accumulation Distribution | 340.24 | |
| Innate Pharma Price Daily Balance Of Power | (0.78) | |
| Innate Pharma Price Rate Of Daily Change | 0.97 | |
| Innate Pharma Price Action Indicator | (0.08) |
Innate Pharma March 19, 2025 Stock Price Analysis
Innate Stock Price History Data
The price series of Innate Pharma for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 1.47 with a coefficient of variation of 11.77. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.98. The median price for the last 90 days is 1.95.| Open | High | Low | Close | Volume | ||
| 03/18/2025 | 2.02 | 2.04 | 1.95 | 1.95 | 7,712 | |
| 03/17/2025 | 2.00 | 2.03 | 1.98 | 2.02 | 2,496 | |
| 03/14/2025 | 1.99 | 2.00 | 1.92 | 2.00 | 17,923 | |
| 03/13/2025 | 1.99 | 2.01 | 1.97 | 2.00 | 9,189 | |
| 03/12/2025 | 2.02 | 2.04 | 2.00 | 2.01 | 7,458 | |
| 03/11/2025 | 2.05 | 2.09 | 2.00 | 2.00 | 8,259 | |
| 03/10/2025 | 2.10 | 2.16 | 2.03 | 2.06 | 27,902 | |
| 03/07/2025 | 2.15 | 2.16 | 2.13 | 2.13 | 10,035 | |
| 03/06/2025 | 2.09 | 2.11 | 2.06 | 2.09 | 6,247 | |
| 03/05/2025 | 2.15 | 2.15 | 2.04 | 2.08 | 32,588 | |
| 03/04/2025 | 2.04 | 2.06 | 1.99 | 1.99 | 28,210 | |
| 03/03/2025 | 2.18 | 2.18 | 2.02 | 2.09 | 24,124 | |
| 02/28/2025 | 2.14 | 2.18 | 2.04 | 2.12 | 41,553 | |
| 02/27/2025 | 2.28 | 2.38 | 2.04 | 2.16 | 82,111 | |
| 02/26/2025 | 2.30 | 2.32 | 2.26 | 2.26 | 33,848 | |
| 02/25/2025 | 2.37 | 2.38 | 2.17 | 2.20 | 136,628 | |
| 02/24/2025 | 2.23 | 2.59 | 2.23 | 2.53 | 438,572 | |
| 02/21/2025 | 2.24 | 2.26 | 2.16 | 2.24 | 117,950 | |
| 02/20/2025 | 2.07 | 2.26 | 2.07 | 2.26 | 224,200 | |
| 02/19/2025 | 2.19 | 2.26 | 2.13 | 2.19 | 372,775 | |
| 02/18/2025 | 2.36 | 2.38 | 2.04 | 2.34 | 11,531,370 | |
| 02/14/2025 | 1.99 | 2.00 | 1.94 | 1.94 | 6,441 | |
| 02/13/2025 | 1.93 | 1.99 | 1.93 | 1.95 | 8,898 | |
| 02/12/2025 | 1.94 | 1.94 | 1.89 | 1.90 | 13,683 | |
| 02/11/2025 | 1.94 | 1.94 | 1.89 | 1.92 | 12,700 | |
| 02/10/2025 | 1.94 | 1.94 | 1.88 | 1.92 | 5,220 | |
| 02/07/2025 | 2.01 | 2.02 | 1.83 | 1.90 | 29,898 | |
| 02/06/2025 | 2.01 | 2.10 | 1.96 | 2.00 | 44,806 | |
| 02/05/2025 | 1.97 | 1.99 | 1.89 | 1.95 | 29,080 | |
| 02/04/2025 | 1.96 | 2.00 | 1.83 | 1.95 | 84,122 | |
| 02/03/2025 | 1.88 | 1.88 | 1.72 | 1.72 | 20,459 | |
| 01/31/2025 | 1.81 | 1.83 | 1.74 | 1.83 | 10,375 | |
| 01/30/2025 | 1.76 | 1.81 | 1.74 | 1.79 | 15,348 | |
| 01/29/2025 | 1.74 | 1.80 | 1.71 | 1.76 | 21,796 | |
| 01/28/2025 | 1.77 | 1.83 | 1.70 | 1.76 | 45,581 | |
| 01/27/2025 | 1.85 | 1.92 | 1.70 | 1.80 | 385,400 | |
| 01/24/2025 | 1.75 | 1.77 | 1.67 | 1.77 | 20,437 | |
| 01/23/2025 | 1.74 | 1.74 | 1.63 | 1.67 | 21,083 | |
| 01/22/2025 | 1.78 | 1.78 | 1.76 | 1.77 | 4,614 | |
| 01/21/2025 | 1.74 | 1.77 | 1.74 | 1.77 | 11,492 | |
| 01/17/2025 | 1.73 | 1.74 | 1.65 | 1.69 | 13,723 | |
| 01/16/2025 | 1.73 | 1.75 | 1.67 | 1.67 | 31,476 | |
| 01/15/2025 | 1.80 | 1.80 | 1.60 | 1.70 | 100,189 | |
| 01/14/2025 | 1.82 | 1.83 | 1.75 | 1.79 | 12,198 | |
| 01/13/2025 | 1.79 | 1.87 | 1.78 | 1.82 | 29,616 | |
| 01/10/2025 | 1.83 | 1.83 | 1.74 | 1.77 | 74,986 | |
| 01/08/2025 | 1.87 | 1.87 | 1.64 | 1.83 | 38,403 | |
| 01/07/2025 | 1.89 | 1.89 | 1.83 | 1.86 | 15,159 | |
| 01/06/2025 | 1.92 | 1.95 | 1.85 | 1.88 | 80,226 | |
| 01/03/2025 | 1.90 | 1.94 | 1.80 | 1.87 | 25,700 | |
| 01/02/2025 | 1.94 | 1.94 | 1.87 | 1.87 | 38,867 | |
| 12/31/2024 | 1.94 | 1.96 | 1.77 | 1.84 | 49,365 | |
| 12/30/2024 | 2.09 | 2.09 | 1.81 | 1.95 | 101,583 | |
| 12/27/2024 | 2.11 | 2.14 | 2.04 | 2.11 | 33,408 | |
| 12/26/2024 | 2.07 | 2.12 | 2.03 | 2.11 | 41,700 | |
| 12/24/2024 | 2.06 | 2.08 | 2.03 | 2.06 | 24,122 | |
| 12/23/2024 | 2.04 | 2.15 | 2.01 | 2.10 | 37,962 | |
| 12/20/2024 | 2.08 | 2.10 | 2.03 | 2.05 | 48,484 | |
| 12/19/2024 | 2.15 | 2.18 | 2.08 | 2.16 | 43,761 | |
| 12/18/2024 | 2.19 | 2.36 | 2.11 | 2.16 | 156,594 | |
| 12/17/2024 | 2.12 | 2.31 | 2.12 | 2.15 | 196,641 |
About Innate Pharma Stock history
Innate Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Innate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Innate Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Innate Pharma stock prices may prove useful in developing a viable investing in Innate Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 92.5 M | 53.1 M | |
| Net Loss | -52.3 M | -49.7 M |
Innate Pharma Quarterly Net Working Capital |
|
Innate Pharma Stock Technical Analysis
Innate Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Innate Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Innate Pharma's price direction in advance. Along with the technical and fundamental analysis of Innate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Innate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0553 | |||
| Jensen Alpha | 0.7868 | |||
| Total Risk Alpha | 2.03 | |||
| Sortino Ratio | 0.1198 | |||
| Treynor Ratio | 0.5484 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Innate Stock analysis
When running Innate Pharma's price analysis, check to measure Innate Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innate Pharma is operating at the current time. Most of Innate Pharma's value examination focuses on studying past and present price action to predict the probability of Innate Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innate Pharma's price. Additionally, you may evaluate how the addition of Innate Pharma to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |